Health Catalyst, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on September 11, 2026. The report discloses corporate governance changes, specifically the appointment of a new director and the expansion of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Expansion: The Board of Directors expanded from six (6) to seven (7) members, effective October 1, 2026.
- Director Appointment: Tami Reller was appointed as a Class III director to fill the newly created seat.
- Committee Assignments: Ms. Reller was appointed to the Audit Committee (replacing Jill Hoggard Green) and designated as Chair of the Audit Committee (replacing Justin Spencer). She was also appointed to the Compensation Committee (replacing Ms. Hoggard Green).
Guidance, Outlook, and Management Commentary
Management stated that Ms. Reller was selected based on her executive leadership experience and knowledge of the healthcare and technology industries. Her background includes senior roles at Duly Health and Care, UnitedHealth Group (Optum and UnitedHealthcare), and Microsoft Corporation. No financial guidance or outlook was provided in this filing.
Investor Verification Checklist
- Verify the effective date of the Board expansion and Ms. Reller's appointment (October 1, 2026).
- Confirm the specific committee roles and the directors being replaced (Jill Hoggard Green and Justin Spencer).
- Review the press release dated September 14, 2026 (Exhibit 99.1) for additional context on the appointment.
- Check the Non-Employee Director Compensation Policy (Exhibit 10.2) for details on Ms. Reller's compensation structure.